Skip to main content
Company record · Liège
Belgian companySituation normaleSociété à responsabilité limitée

PHARMALEX

Enterprise number
0471.925.883
VAT number
BE0471925883
Registered office
Rue de Mulhouse 33, 4020 Liège
See the 6 companies at this address
Incorporated on
19 May 2000
Members only
Health score
Latest financial year
2022
m81-f model
Size
Not published
Workforce not declared
Equity
€1.9M
Financial year 2022
Net result
€176.6K
Financial year 2022

Profile

Official information from the CBE (FPS Economy).

PHARMALEX is a Belgian company (Société à responsabilité limitée) whose registered office is established at 4020 Liège. Its main activity falls under “Activités des experts-comptables (fiscalistes) (certifiés)” (NACE 69201).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
19 May 2000

Anti-money-laundering (AML) compliance

Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.

Obliged entityEconomic profession (accountant, tax adviser, auditor)

Given its declared activity (“Activités des experts-comptables (fiscalistes) (certifiés)”), PHARMALEX belongs to a profession expressly covered by Belgian anti-money-laundering law.

Chartered accountants, tax advisers, accountants (ITAA), statutory auditors (IRE) and non-regulated tax advisers are obliged entities.

Applicable obligations
  • Identification and verification of the client's identity (KYC)
  • Identification of the ultimate beneficial owners (UBO register)
  • Assessment of money-laundering and terrorist-financing risks
  • Ongoing diligence and monitoring of transactions
  • Reporting suspicions to the CTIF
  • Retention of the documents and appointment of an AMLCO

Legal basis: art. 5, §1, 23°, 24°, 25° and 25°/1 of the Act of 18 September 2017.

General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.

Your risk analysis on this company

AML Company ran PHARMALEX through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Liège

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Rue de Mulhouse 33
4020 Liège
Map
Establishment2229.125.029
Rue de Mulhouse 33
4020 Liège
Map

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2022€1,900,177€176,576
2021––
2020––
2019––

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
80,1%
Financial year 2022

Equity / balance sheet total

Liquidity
3,38 x
Financial year 2022

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
-

This year's filing does not carry the item the calculation needs.

Debts due after one year / balance sheet total

Return on equity
9,3%
Financial year 2022

Result for the year / equity

Year-on-year comparison
Ratio202220212020Trend
Solvency
80,1%
--
-
Liquidity
3,38 x
--
-
Net margin---
-
Operating margin---
-
Long-term debt---
-
Return on equity
9,3%
--
-

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (5)▾
Financial yearFilingFiling typeModelSource
01/01/2022 → 30/06/202223/12/2022Initialm81-fBNB
01/01/2021 → 31/12/202128/03/2022Initialm81-fBNB
01/01/2020 → 31/12/202031/05/2021Initialm81-fBNB
01/01/2019 → 31/12/201916/07/2020Initialm01-fBNB
01/01/2018 → 31/12/201829/03/2019Initialm01-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

What the PHARMALEX record does not say

Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.

Is PHARMALEX subject to anti-money-laundering obligations in Belgium?
Yes, on the basis of the activity code declared in the register (Economic profession (accountant, tax adviser, auditor), art. 5, §1, 23°, 24°, 25° and 25°/1 of the Act of 18 September 2017). Chartered accountants, tax advisers, accountants (ITAA), statutory auditors (IRE) and non-regulated tax advisers are obliged entities. PHARMALEX must therefore identify its clients and their beneficial owners, monitor its transactions and report its suspicions to the CTIF-CFI. An indicative verdict, to be checked against the activity actually carried out.
Did PHARMALEX file its annual accounts on time?
Yes. PHARMALEX filed its latest annual accounts with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 23 December 2022, ahead of 30 January 2023. Article 3:10 of the Code of Companies and Associations requires filing within thirty days of approval and at the latest seven months after the financial year closes.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
10 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 3 August 2026Corporate purpose · Articles of association · Appointments · Resignations · MiscellaneousView the notice26350310
  2. 2023
    1. 28 February 2023Appointments · ResignationsView the notice23028863
  3. 2022
    1. 23 December 2022Annual accounts filed·Financial year ended 30 June 2022 · Model m81-fFiled accounts2023-20552485
    2. 28 June 2022Corporate purpose · Legal form · General meeting · Appointments · Resignations · Financial yearView the notice22341289
    3. 28 March 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m81-fFiled accounts2022-08700540
  4. 2021
    1. 31 May 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m81-fFiled accounts2021-16200284
  5. 2020
    1. 16 July 2020Annual accounts filed·Financial year ended 31 December 2019 · Model m01-fFiled accounts2020-31000442
  6. 2019
    1. 29 March 2019Annual accounts filed·Financial year ended 31 December 2018 · Model m01-fFiled accounts2019-08700355
  7. 2018
    1. 22 January 2018Capital · SharesView the notice18015203
  8. 2013
    1. 19 December 2013Capital · SharesView the notice13191180

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, audience-measurement cookies (hosted in the EU) to improve our services. Learn more.